Impact of team‐based pharmaceutical care on the humanistic outcomes among patients with long‐standing diabetes: An interim analysis of a randomized, controlled, multicenter study
- 18 March 2021
- journal article
- research article
- Published by Wiley in JACCP: Journal of the American College of Clinical Pharmacy
- Vol. 4 (6) , 680-688
Abstract
Introduction: Epidemiological studies have reported that diabetes‐related complications increase after 5 years of uncontrolled/suboptimal metabolic control. The risk of experiencing diabetes‐related microvascular diseases usually spike after 10 years of uncontrolled diabetes.Objectives: The objective of this study was to evaluate the impact of team‐based pharmaceutical care on glycemic control, self‐care, diabetes‐dependent quality of life, and productivity loss in patients with long‐standing diabetes (≥5 years).Methods: This was a prospective, multicenter, randomized, controlled study. Patients with a glycosylated hemoglobin (HbA1c) > 7%, long‐standing diabetes defined as having a disease duration of at least 5 years, and polypharmacy defined as taking 5 or more chronic medications were included in the study. Patients in the intervention arm received team‐based pharmaceutical care regularly while patients in the control arm received physician‐centered care. Patients' humanistic outcomes were followed for 6 months.Results: A total of 248 patients (126 intervention and 122 control) were included in the study. In addition to improved glycemic control observed in the intervention arm (mean difference: 0.44%, P = .003, 95% confidence interval: [0.15, 0.73]), the intervention arm showed significant improvements in overall self‐care level (+0.36, 95% confidence interval: [0.01, 0.72], P = .045) and self‐monitoring of blood glucose (+1.87, 95% confidence interval: [1.00, 2.99], P < .001) compared with the control arm. There were no significant differences in the changes in diabetes‐associated quality of life and overall work impairment between the two arms. A significant difference in activity impairment (affected productivity in regular unpaid activity) between the two arms was found, with 43.3% impairment having occurred in the control group vs 27.9% in the intervention group (P = .047).Conclusion: Team‐based pharmaceutical care significantly improved overall self‐care and glycemia without deteriorating quality of life and incurring productivity loss. Our findings highlighted the value of team‐based pharmaceutical care in managing diabetes‐experienced patients.Keywords
This publication has 45 references indexed in Scilit:
- Pharmacist consultations in general practice clinics: The Pharmacists in Practice Study (PIPS)Research in Social and Administrative Pharmacy, 2014
- Diabetes Attitudes, Wishes and Needs second study (DAWN2™): Cross‐national benchmarking of diabetes‐related psychosocial outcomes for people with diabetesDiabetic Medicine, 2013
- Role of self-care in management of diabetes mellitusJournal of Diabetes & Metabolic Disorders, 2013
- Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomesJournal of Clinical Epidemiology, 2012
- Do physicians understand Type 2 diabetes patients’ perceptions of seriousness; the emotional impact and needs for care improvement? A cross-national surveyPatient Education and Counseling, 2011
- Impact of Diabetes on Cardiovascular Disease Risk and All-Cause Mortality in Older MenArchives of internal medicine (1960), 2011
- Audit of Diabetes-Dependent Quality of Life (ADDQoL) [Chinese Version for Singapore] QuestionnaireApplied Health Economics and Health Policy, 2010
- Outcomes of pharmacist-managed diabetes care services in a community health centerAmerican Journal of Health-System Pharmacy, 2006
- The summary of diabetes self-care activities measure: results from 7 studies and a revised scale.Diabetes Care, 2000
- The Validity and Reproducibility of a Work Productivity and Activity Impairment InstrumentPharmacoEconomics, 1993